Reversion of malignant phenotypes of human glioblastoma cells by β-elemene through β-catenin-mediated regulation of stemness-, differentiation- and epithelial-to-mesenchymal transition-related molecules

Journal of Translational Medicine

Volumn 13, Issue 1, 2015, Pages

  Zhu, Tingzhun ^a   Li, Xiaoming ^a   Luo, Lihan ^b   Wang, Xiaogang ^a   Li, Zhiqing ^a   Xie, Peng ^a   Gao, Xu ^a   Song, Zhenquan ^a   Su, Jingyuan ^a   Liang, Guobiao ^a  

^a GENERAL HOSPITAL OF NORTHERN THEATER COMMAND   (China)

^b Shenyang Entry Exit Inspection and Quarantine Bureau   (China)

Author keywords

Glioblastoma; Malignant phenotype; Catenin; Elemene

Indexed keywords

BETA CATENIN; BETA ELEMENE; BREAST CANCER RESISTANCE PROTEIN; CD133 ANTIGEN; GLIAL FIBRILLARY ACIDIC PROTEIN; NERVE CELL ADHESION MOLECULE; NOTCH1 RECEPTOR; SONIC HEDGEHOG PROTEIN; UVOMORULIN; VIMENTIN; BETA-ELEMENE; SESQUITERPENE;

ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; ANTIPROLIFERATIVE ACTIVITY; APOPTOSIS; ARTICLE; CANCER CELL; CASE REPORT; CELL DIFFERENTIATION; CELL PROLIFERATION; CELL SURVIVAL; CELL VIABILITY; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG MECHANISM; EPITHELIAL MESENCHYMAL TRANSITION; FEMALE; FLOW CYTOMETRY; GLIOBLASTOMA; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; IN VIVO STUDY; MALE; MIDDLE AGED; MOUSE; NONHUMAN; PROTEIN EXPRESSION; TUMOR VOLUME; TUMOR XENOGRAFT; WESTERN BLOTTING; ANIMAL; BRAIN TUMOR; CANCER STEM CELL; DRUG EFFECTS; METABOLISM; NUDE MOUSE; PATHOLOGY; TUMOR CELL LINE; TUMOR INVASION; XENOGRAFT;

ANIMALS; BETA CATENIN; BRAIN NEOPLASMS; CELL DIFFERENTIATION; CELL LINE, TUMOR; CELL PROLIFERATION; EPITHELIAL-MESENCHYMAL TRANSITION; GLIOBLASTOMA; HETEROGRAFTS; HUMANS; MICE; MICE, NUDE; NEOPLASM INVASIVENESS; NEOPLASTIC STEM CELLS; SESQUITERPENES;

EID: 84946829346     PISSN: None     EISSN: 14795876     Source Type: Journal    
DOI: 10.1186/s12967-015-0727-2     Document Type: Article

References (47)

1. Van Meir EG, Hadjipanayis CG, Norden AD, Shu HK, Wen PY, Olson JJ. Exciting new advances in neuro-oncology: the avenue to a cure for malignant glioma. CA Cancer J Clin. 2010;60:166-93.
2. Omuro A, DeAngelis LM. Glioblastoma and other malignant gliomas: a clinical review. JAMA. 2013;310:1842-50.
3. Shah U, Morrison T. A review of the symptomatic management of malignant gliomas in adults. J Natl Compr Canc Netw. 2013;11:424-9.
4. Eyüpoglu IY, Buchfelder M, Savaskan NE. Surgical resection of malignant gliomas-role in optimizing patient outcome. Nat Rev Neurol. 2013;9:141-51.
5. Chen SL, You J, Wang GJ. Supercritical fluid extraction of β-elemene under lower pressure. Se Pu. 2001;19:179-81 (in Chinese).
6. Zhang X, Zhang Y, Li Y. β-elemene decreases cell invasion by upregulating E-cadherin expression in MCF-7 human breast cancer cells. Oncol Rep. 2013;30:745-50.
7. Zhu T, Zhao Y, Zhang J, Li L, Zou L, Yao Y, et al. β-Elemene inhibits proliferation of human glioblastoma cells and causes cell-cycle g0/g1 arrest via mutually compensatory activation of MKK3 and MKK6. Int J Oncol. 2011;38:419-26.
8. Yao YQ, Ding X, Jia YC, Huang CX, Wang YZ, Xu YH. Anti-tumor effect of beta-elemene in glioblastoma cells depends on p38 MAPK activation. Cancer Lett. 2008;264:127-34.
9. Zhu T, Xu Y, Dong B, Zhang J, Wei Z, Xu Y, et al. β-Elemene inhibits proliferation of human glioblastoma cells through the activation of gliamaturation factor β and induces sensitization to cisplatin. Oncol Rep. 2011;26:405-13.
10. Zhao YS, Zhu TZ, Yao YQ, Wu CM, Wei ZQ, Wang W, et al. β-Elemene inhibits Hsp90/Raf-1 molecular complex inducing apoptosis of glioblastoma cells. J Neuro-oncol. 2012;107:307-14.
11. Zhu TZ, Li XM, Luo LH, Song ZQ, Gao X, Li ZQ, et al. β-Elemene inhibits stemness promotes differentiation and impairs chemoresistance to temozolomide in glioblastoma stem-like cells. Int J Oncol. 2014;45:699-709.
12. Lathia JD, Mack SC, Mulkearns-Hubert EE, Valentim CL, Rich JN. Cancer stem cells in glioblastoma. Genes Dev. 2015;29:1203-17.
13. Choy W, Nagasawa DT, Trang A, Thill K, Spasic M, Yang I. CD133 as a marker for regulation and potential for targeted therapies in glioblastoma multiforme. Neurosurg Clin N Am. 2012;23:391-405.
14. + glioma cells with higher Rac1 activity. Chin Med J (Engl). 2012;125:4344-8.
15. Singh SK, Clarke ID, Terasaki M, Bonn VE, Hawkins C, Squire J, et al. Identification of a cancer stem cell in human brain tumors. Cancer Res. 2003;63:5821-8.
16. Ding XW, Wu JH, Jiang CP. ABCG2: a potential marker of stem cells and novel target in stem cell and cancer therapy. Life Sci. 2010;86:631-7.
17. Dean M, Fojo T, Bates S. Tumour stem cells and drug resistance. Nat Rev Cancer. 2005;5:275-84.
18. Bleau AM, Huse JT, Holland EC. The ABCG2 resistance network of glioblastoma. Cell Cycle. 2009;8:2936-44.
19. Scharenberg CW, Harkey MA, Torok-Storb B. The ABCG2 transporter is an efficient Hoechst 33342 efflux pump and is preferentially expressed by immature human hematopoietic progenitors. Blood. 2002;99:507-12.
20. Nakanishi T, Ross DD. Breast cancer resistance protein (BCRP/ABCG2): its role in multidrug resistance and regulation of its gene expression. Chin J Cancer. 2012;31:73-99.
21. Dell'albani P, Rodolico M, Pellitteri R, Tricarichi E, Torrisi SA, D'Antoni S, et al. Differential patterns of NOTCH1-4 receptor expression are markers of glioma cell differentiation. Neuro Oncol. 2014;16:204-16.
22. Ghezali L, Liagre B, Limami Y, Beneytout JL, Leger DY. Sonic Hedgehog activation is implicated in diosgenin-induced megakaryocytic differentiation of human erythroleukemia cells. PLoS One. 2014;9:e95016.
23. Huang JG, Shen CB, Wu WB, Ren JW, Xu L, Liu S, et al. Primary cilia mediate sonic hedgehog signaling to regulate neuronal-like differentiation of bone mesenchymal stem cells for resveratrol induction in vitro. J Neurosci Res. 2014;92:587-96.
24. Adhikary A, Chakraborty S, Mazumdar M, Ghosh S, Mukherjee S, Manna A, et al. Inhibition of Epithelial to Mesenchymal transition by E-cadherin up-regulation via repression of Slug transcription and inhibition of E-cadherin degradation: dual role of SMAR1 in breast cancer cells. J Biol Chem. 2014;289:25431-44.
25. Bronsert P, Enderle-Ammour K, Bader M, Timme S, Kuehs M, Csanadi A, et al. Cancer cell invasion and EMT marker expression-a three-dimensional study of the human cancer-host interface. J Pathol. 2014;234:410-22.
26. Zhang K, Zhu S, Liu Y, Dong X, Shi Z, Zhang A, et al. ICAT inhibits glioblastoma cell proliferation by suppressing Wnt/β-catenin activity. Cancer Lett. 2015;357:404-11.
27. Chen X, Hu W, Xie B, Gao H, Xu C, Chen J. Downregulation of SCAI enhances glioma cell invasion and stem cell like phenotype by activating Wnt/β-catenin signaling. Biochem Biophys Res Commun. 2014;448:206-11.
28. Chen HL, Chew LJ, Packer RJ, Gallo V. Modulation of the Wnt/beta-catenin pathway in human oligodendroglioma cells by Sox17 regulates proliferation and differentiation. Cancer Lett. 2013;335:361-71.
29. Wang Y, Zeng S, Lin TM, Krugner-Higby L, Lyman D, Steffen D, et al. Evaluating the Anticancer Properties of Liposomal Copper in a Nude Xenograft Mouse Model of Human Prostate Cancer: formulation, In vitro, In vivo, Histology and Tissue Distribution Studies. Pharm Res. 2014;31:3106-19.
30. Mantwill K, Naumann U, Seznec J, Girbinger V, Lage H, Surowiak P, et al. YB-1 dependent oncolytic adenovirus efficiently inhibits tumor growth of glioma cancer stem like cells. J Transl Med. 2013;11:216.
31. Beier D, Schulz JB, Beier CP. Chemoresistance of glioblastoma cancer stem cells-much more complex than expected. Mol Cancer. 2011;10:128.
32. + cancer stem cells in glioblastoma. Mol Cancer. 2006;5:67.
33. Baumgart A, Mazur PK, Anton M, Rudelius M, Schwamborn K, Feuchtinger A, et al. Opposing role of Notch1 and Notch2 in a KrasG12D-driven murine non-small cell lung cancer model. Oncogene. 2015;34:578-88.
34. Liao Y, He X, Qiu H, Che Q, Wang F, Lu W, et al. Suppression of the epithelial-mesenchymal transition by SHARP1 is linked to the Notch1 signaling pathway inmetastasis of endometrial cancer. BMC Cancer. 2014;14:487.
35. Angulo-Rojo C, Manning-Cela R, Aguirre A, Ortega A, López-Bayghen E. Involvement of the Notch pathway in terminal astrocytic differentiation: role of PKA. ASN Neuro. 2013;5:e00130.
36. Patel PN, Yu XM, Jaskula-Sztul R, Chen H. Hesperetin activates the notch1 signaling cascade, causes apoptosis, and induces cellular differentiation in anaplastic thyroid cancer. Ann Surg Oncol. 2014;21:497-504.
37. Du WZ, Feng Y, Wang XF, Piao XY, Cui YQ, Chen LC, et al. Curcumin suppresses malignant glioma cells growth and induces apoptosis by inhibition of SHH/GLI1 signaling pathway in vitro and vivo. CNS Neurosci Ther. 2013;19:926-36.
38. Mao Y, Xu J, Li Z, Zhang N, Yin H, Liu Z. The role of nuclear β-catenin accumulation in the Twist2-induced ovarian cancer EMT. PLoS One. 2013;8:e78200.
39. Hsu PC, Liao YF, Lin CL, Lin WH, Liu GY, Hung HC. Vimentin is involved in peptidylarginine deiminase 2-induced apoptosis of activated Jurkat cells. Mol Cells. 2014;37:426-34.
40. Wu TF, Chen JM, Chen SS, Chen GL, Wei YX, Xie XS, et al. Phenotype of SHG-44 glioma stem cell spheres and pathological characteristics of their xenograft tumors. Zhonghua Zhong Liu Za Zhi. 2013;35:726-31 (in Chinese).
41. Maguschak KA, Ressler KJ. The dynamic role of beta-catenin in synaptic plasticity. Neuropharmacology. 2012;62:78-88.
42. Fransvea E, Angelotti U, Antonaci S, Giannelli G. Blocking transforming growth factor-beta up-regulates E-cadherin and reduces migration and invasion of hepatocellular carcinoma cells. Hepatology. 2008;47:1557-66.
43. Wang Y, Zhang Y, Qian C, Cai M, Li Y, Li Z, et al. GSK3β/β-catenin signaling is correlated with the differentiation of glioma cells induced by wogonin. Toxicol Lett. 2013;222:212-23.
44. Selvadurai HJ, Mason JO. Activation of Wnt/β-catenin signalling affects differentiation of cells arising from the cerebellar ventricular zone. PLoS One. 2012;7:e42572.
45. Lu Z, Liu H, Xue L, Xu P, Gong T, Hou G. An activated Notch1 signaling pathway inhibits cell proliferation and induces apoptosis in human esophageal squamous cell carcinoma cell line EC9706. Int J Oncol. 2008;32:643-51.
46. Zhao L, Li W, Zang W, Liu Z, Xu X, Yu H, et al. JMJD2B promotes epithelial-mesenchymal transition by cooperating with β-catenin and enhances gastric cancer metastasis. Clin Cancer Res. 2013;19:6419-29.
47. D'Arcy P, Maruwge W, Wolahan B, Ma L, Brodin B. Oncogenic functions of the cancer-testis antigen SSX on the proliferation, survival, and signaling pathways of cancer cells. PLoS One. 2014;9:e95136.